These drugs have also caused new or worsening kidney disease, including kidney failure, in some people
Researchers from the University of Oxford, led by postdoctoral researcher Sam West, examined 37 clinical studies published up to February 2025, involving more than 9,000 participants who had taken obesity medications, including GLP-1 receptor agonists, for an average of 39 weeks
13. Wang, Y., Yen, F.S., Zhu, X.G., Timson, R.C., Weber, R., Xing, C., Liu, Y., Allwein, B., Luo, H., Yeh, H.W., et al
Study link in comments with tips on how to use light therapy (and new recommendations for LED boxes)
Yet, we found no evidence that this is the case with WMM, as cardiometabolic health markers returned to baseline within 1.4 years after stopping treatment
A few small habits can protect your medication and help you stay consistent with your treatment